Safety


  • SGNA Special
    U.S. Endoscopy GroupBooth 321 The newly designed Roth Netâ„¢ is the premier device for both polyp and foreign body retrieval. Improvements to this patented innovation include the "easy-pack" net delivery system, a stiffer loop wire and a reinforced sheath. All of these ...More
    May 1, 2002 Posted in Articles, Industry Issues, Procedures
  • Endo Nerds Unite!
    While surfing the Internet to scan national newspapers, I came upon a headline that made me jump: "Hospital Says Faulty Recall May Have exposed 400 to Infection." I read the online article quickly, hurried to the printer to review the text again and furiously made interview ...More
    May 1, 2002 Posted in Articles, Industry Issues
  • Hep A Vaccine May Provide 30 Years of Protection
    LONDON - Researchers studying the lasting effects of GlaxoSmithKline's hepatitis A vaccine Havrix say the inoculation may provide 30 years, rather than 10 years, of protection. Following 155 adults who were vaccinated with Havrix in 1990, the team followed a mathematical ...More
    March 26, 2002 Posted in News, Disorders, Industry Issues
  • Hepatitis B, Carotid Atherosclerosis Linked
    NEW YORK - Japanese researchers have reportedly found a tie between chronic hepatitis B (HBV) and carotid atherosclerosis. The team's report, published in the Journal of the American Heart Association, details the population-based study. Studying 4,686 men and women aged ...More
    March 18, 2002 Posted in News, Disorders, Industry Issues
  • Applied Medical GelPort
    Applied Medical, headquartered in Rancho Santa Margarita, Calif, has developed the GelPort Hand Access Device to combine the patient outcomes of minimally invasive surgery with the speed and precision of open surgery. The GelPort Hand Access Laparoscope allows a surgeon and ...More
    March 1, 2002 Posted in Articles, Industry Issues, Procedures
  • Latex Allergy Update
    Often thought of as a modern-day malady, allergic reactions to rubber gloves were first reported in the early 1930s. The number of reported reactions rapidly increased as the consumption of medical gloves rose after the implementation of Universal Precautions during the ...More
    March 1, 2002 Posted in Articles, Disorders, Industry Issues, Procedures
  • Hepatitis Patient Wins Transfusion Case
    BUDAPEST, Hungaria-A Hungarian court has ruled in favor of a patient infected with hepatitis C via blood transfusion. The Pest Central District Court ruled the responsible hospital will have to pay $10,7000 in damages and a monthly allowance of $53 to the patient. There are ...More
    January 30, 2002 Posted in News, Disorders, Industry Issues
  • Surgical Glue Receives FDA Approval
    WASHINGTON, DC--The US Food and Drug Administration (FDA) has approved Dermabond--a glue specifically designed to seal surgical cuts without stitches. The glue reportedly keeps out bacteria as well. Distributed by Ethicon Products, a division of Johnson & Johnson, the ...More
    January 18, 2002 Posted in News, Industry Issues
  • Antibody Shows Positive Results in Hep C Trial
    REHOVOT, Israel-Officials from XTL Biopharmaceuticals are reporting positive results of the first monoclonal antibody to treat hepatitis C (HCV). XTL-002, the company's monoclonal antibody, has been tested in Phase 1a studies and has reportedly reduced HCV and RNA levels in ...More
    January 14, 2002 Posted in News, Disorders, Industry Issues
  • Adjuvant Successful in Phase III Hepatitis study
    NEW YORK-Researchers from Corixa Corp and Rhein Biotech NC have announced their phase III hepatitis B vaccine study results. The vaccine provided more efficacious protection against the hepatitis B virus when combined with Corixa's RC-529 synthetic adjuvant. The adjuvant ...More
    January 10, 2002 Posted in News, Disorders, Industry Issues